Purchase Order HHSN268201400035P

<p>The National Heart Lung and Blood Institute awarded a purchase order to Roche Diagnostics Corporation for $25,138.89 on December 23, 2013, with completion by July 17, 2014. Place of performance is North Bethesda, Maryland. The order is priced firm fixed price for in vitro diagnostic supplies and reagents supporting the Institute's clinical laboratory operations.</p>

<p>The National Heart Lung and Blood Institute issued a purchase order to Roche Diagnostics Corporation valued at $40,000.00 on February 1, 2013, with ultimate completion on January 31, 2014.</p> <p>Performance takes place in Bethesda, Maryland. The order carries firm fixed-price pricing with no set-aside designation. Roche Diagnostics supplies in vitro diagnostic products, laboratory instruments, reagents, and associated medical technologies to federal healthcare agencies.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Roche Diagnostics Corporation valued at $33,333.33 on April 29, 2013, with completion by January 16, 2014. Performance takes place in Bethesda, Maryland. The order is firm fixed-price with no set-aside applied. The source does not specify the goods or services procured.</p>

<p>The National Heart Lung and Blood Institute issued a purchase order to Roche Diagnostics Corporation on January 19, 2012, for maintenance, repair, and rebuild of laboratory instruments and equipment, with a ceiling value of $45,000 and firm fixed-price terms. Place of performance is Bethesda, Maryland. The order is scheduled for ultimate completion on January 31, 2013. No set-aside category applied to this procurement.</p>

<p>The National Institutes of Health Clinical Center awarded a purchase order to Roche Diagnostics Corporation for $23,977.00 on May 17, 2013. Place of performance is Bethesda, Maryland. The order, which closed on December 31, 2013, covers diagnostic equipment, reagents, laboratory instruments, or associated medical products supplied under firm fixed-price terms. No set-aside applied.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Bio-Rad Laboratories, Inc. for $9,240.00 on October 4, 2012, with ultimate completion on October 4, 2013. The order covers maintenance, repair, and rebuild of laboratory instruments and equipment on a firm fixed-price basis. Work is performed at Bethesda, Maryland.</p>

<p>The National Heart Lung and Blood Institute issued a purchase order to Life Technologies Corporation for $7,341.84 on December 9, 2013, with completion on December 9, 2014. The order covers a maintenance agreement, with place of performance in Bethesda, Maryland. Pricing is firm fixed price with no small business set-aside.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Roche Diagnostics Corporation valued at $18,788.00 on August 19, 2014. Work is performed in North Bethesda, Maryland. The order covers in vitro diagnostic equipment, reagents, or laboratory instruments under fixed-price terms with economic price adjustment. Ultimate completion is scheduled for September 18, 2014.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Illumina, Inc. for $45,726.00 on June 23, 2011, with an ultimate completion date of August 12, 2012. The order covers maintenance and repair of instruments and laboratory equipment. Performance takes place in Bethesda, Maryland. Pricing is firm fixed price with no set-aside category applied.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Rees Scientific Corporation on June 14, 2011, for maintenance and repair of instruments and laboratory equipment, with a ceiling value of $8,200.55 and an ultimate completion date of June 30, 2012.</p> <p>Work is performed at Bethesda, Maryland. The order carries firm fixed-price pricing and no set-aside designation.</p>